ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002